Benson Hill to Host Introductory Webcast and Q&A for Retail Investors Interested in Learning More About the Sustainable Food Technology Company Driving the Plant-Based Food Revolution

Event Will Provide Retail Investors Same Access as Institutional Investors Ahead of the Company’s Expected Listing on New York Stock Exchange

Company Will Leverage Say Connect to Crowdsource Questions for Webcast, in Addition to Ongoing Quarterly Earnings Calls Following Expected Close of Merger Transaction with Star Peak Corp II (NYSE: STPC)

PR Newswire

ST. LOUIS, Sept. 9, 2021 /PRNewswire/ — Benson Hill, Inc. (“Benson Hill,” or the “Company”), a food technology company unlocking the natural genetic diversity of plants with its cutting edge food innovation engine, today announced it will host a webcast and Q&A for retail investors interested in learning more about the Company ahead of its expected listing on the New York Stock Exchange later this month. The Company expects to complete a merger with Star Peak Corp II (“Star Peak“), a publicly traded special purpose acquisition company (NYSE: STPC) in the sustainability space. The Company expects the transaction to close by the end of September, subject to approval of Star Peak stockholders at a special meeting scheduled for September 28, 2021 and the satisfaction or waiver (as applicable) of all other closing conditions.

As a public company, Benson Hill is committed to transparency with investors, regardless of their size and economic stake. To help facilitate these connections and enhance engagement, Benson Hill is partnering with Say Technologies, (“Say”) a Robinhood Markets company, that has built an innovative communication platform to make it easier for investors to exercise their ownership rights. Benson Hill will utilize Say Connect to solicit questions from investors ahead of a special retail-focused webcast on September 17, 2021 at 11:00 a.m. ET. The Company will also utilize the Say Connect platform in connection with quarterly earnings calls following the completion of its transaction with Star Peak.

Starting today, retail investors who are current holders of Star Peak stock, can submit and upvote questions to management. To submit questions, please visit the Say Connect platform at: https://app.saytechnologies.com/bensonhill-2021-september. Shareholders with brokers at Say Technologies can participate directly through their individual investing app or broker website. Retail investors who are not current holders of Star Peak stock can submit questions to [email protected]. Questions can be submitted through September 13, 2021.

“Benson Hill is a company with a bold mission to change how we think about and produce food, and we’re extending that approach to how we show up as a public company,” said Matt Crisp, Chief Executive Officer of Benson Hill. “Consumers are driving revolutionary changes in our food system, which is also helping power our business. As investors, they deserve to have the same access as the largest financial institutions. By partnering with Say ahead of our expected listing, we wish to engage with our retail stakeholders and operate in a different way from traditional public companies.”

“We’re excited that Benson Hill has partnered with Say to more meaningfully connect with its investors ahead of its listing as a public company,” said Zach Hascoe, co-founder of Say Technologies. “Benson Hill is joining a growing number of public companies giving their shareholders the tools they need to make their voices heard by leveraging Say Connect.”

The Company will respond to questions from retail investors on a webcast scheduled for September 17, 2021 at 11:00 am ET. A link to the webcast can be found at https://bensonhill.zoom.us/j/99439020066 and on the Benson Hill investor website at https://bensonhill.com/investors/.

About Benson Hill

Benson Hill moves food forward with the CropOS® platform, a cutting-edge food innovation engine that combines data science and machine learning with biology and genetics. Benson Hill empowers innovators to unlock nature’s genetic diversity from plant to plate, with the purpose of creating healthier, great-tasting food and ingredient options that are both widely accessible and sustainable. More information can be found at bensonhill.com or on Twitter at @bensonhillinc.

On May 10, 2021, Benson Hill announced a definitive business combination agreement with Star Peak Corp II (NYSE: STPC). Upon the closing of the business combination, Benson Hill will become publicly traded on the New York Stock Exchange under the new ticker symbol “BHIL”. Additional information about the transaction can be viewed at: https://bensonhill.com/investors/ or https://stpc.starpeakcorp.com/.

A Special Meeting to approve the pending business combination between Star Peak and Benson Hill, among other items, has been scheduled for September 28, 2021 at 11 a.m. ET. All stockholders as of August 9, 2021 are encouraged to vote their shares by September 27, 2021 at 11:59 p.m. ET. More information on how to vote can be found at: https://stpc.starpeakcorp.com/How-to-Vote/.

Additional Information

This communication is being made in respect of a proposed merger transaction (the “proposed transactions”) involving Star Peak and Benson Hill. The proposed transactions will be submitted to stockholders of Star Peak for their consideration and approval at a special meeting of stockholders. In connection with the proposed transactions, Star Peak has filed a Registration Statement on Form S-4 (the “Registration Statement”) with the Securities and Exchange Commission (“SEC”) and a definitive proxy statement / prospectus to be distributed to Star Peak stockholders in connection with Star Peak’s solicitation for proxies for the vote by Star Peak’s stockholders in connection with the proposed transactions and other matters as described in such Registration Statement, as well as the prospectus relating to the offer of the securities. Star Peak is mailing a definitive proxy statement / prospectus and other relevant documents to its stockholders as of the record date established for voting on the proposed transactions. Investors and security holders of Star Peak are advised to read the definitive proxy statement / prospectus in connection with Star Peak’s solicitation of proxies for its special meeting of stockholders to be held to approve the proposed transaction because the proxy statement / prospectus contains important information about the proposed transaction and the parties to the proposed transaction. Stockholders may also obtain copies of the definitive proxy statement / prospectus, without charge at the SEC’s website at www.sec.gov or by directing a request to: Star Peak Corp II, 1603 Orrington Ave., 13th Floor Evanston, IL 60201.

No Offer or Solicitation

This communication does not constitute an offer to sell or the solicitation of an offer to buy any securities, or a solicitation of any vote or approval, nor shall there be any sale of securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction. No offering of securities shall be made except by means of a prospectus meeting the requirements of Section 10 of the Securities Act of 1933, as amended.

Participants in the Solicitation

Star Peak and Benson Hill and their respective directors, executive officers, other members of management, and employees, under SEC rules, may be deemed to be participants in the solicitation of proxies of Star Peak’s stockholders in connection with the proposed transaction. Information regarding the persons who may, under SEC rules, be deemed participants in the solicitation of proxies in connection with the proposed transaction, including a description of their direct or indirect interests, by security holdings or otherwise, is set forth in the Registration Statement that has been filed with the SEC by Star Peak, which includes the proxy statement / prospectus for the proposed transaction. Information regarding the directors and executive officers of Star Peak is contained in Star Peak’s filings with the SEC, and such information is also in the Registration Statement that has been filed with the SEC by Star Peak, which includes the proxy statement / prospectus for the proposed transaction.

Forward-Looking Statements

Certain statements in this press release may be considered “forward-looking statements” within the meaning of the “safe harbor” provisions of the United States Private Securities Litigation Reform Act of 1995. Forward-looking statements generally relate to future events or Star Peak’s or Benson Hill’s future financial or operating performance. These forward-looking statements include, but are not limited to, statements regarding estimates and forecasts of other financial and performance metrics and projections of market opportunity. In some cases, you can identify forward-looking statements by terminology such as “may,” “should,” “expect,” “intend,” “will,” “estimate,” “anticipate,” “believe,” “predict,” or the negatives of these terms or variations of them or similar terminology. Such forward-looking statements are subject to risks, uncertainties, and other factors which could cause actual results to differ materially from those expressed or implied by such forward-looking statements. These forward-looking statements are based upon estimates and assumptions that, while considered reasonable by Star Peak and its management, and Benson Hill and its management, as the case may be, are inherently uncertain factors that may cause actual results to differ materially from current expectations include, but are not limited to: 1) the occurrence of any event, change or other circumstances that could give rise to the termination of the definitive merger agreement with respect to the business combination; 2) the outcome of any legal proceedings that may be instituted against Star Peak, the combined company or others following the announcement of the business combination and any definitive agreements with respect thereto; 3) the inability to complete the business combination due to the failure to obtain approval of the stockholders of Star Peak, to obtain financing to complete the business combination or to satisfy other conditions to closing; 4) changes to the proposed structure of the business combination that may be required or appropriate as a result of applicable laws or regulations or as a condition to obtaining regulatory approval of the business combination; 5) the ability to meet the NYSE’s listing standards following the consummation of the business combination; 6) the risk that the business combination disrupts current plans and operations of Benson Hill as a result of the announcement and consummation of the business combination; 7) the ability to recognize the anticipated benefits of the business combination, which may be affected by, among other things, competition, the ability of the combined company to grow and manage growth profitably, maintain relationships with customers and suppliers and retain its management and key employees; 8) costs related to the business combination; 9) changes in applicable laws or regulations; 10) the possibility that Benson Hill or the combined company may be adversely affected by other economic, business and/or competitive factors; 11) Benson Hill’s estimates of its financial performance; 12) the impact of the COVID-19 pandemic and its effect on business and financial conditions; and 13) other risks and uncertainties set forth in the sections entitled “Risk Factors” and “Cautionary Note Regarding Forward-Looking Statements” in Star Peak’s Annual Report on Form 10-K for the year ended December 31, 2020, filed with the SEC on March 31, 2021, in the proxy statement / prospectus relating to the proposed business combination (when available), and other documents filed or to be filed with the SEC by Star Peak. Nothing in this press release should be regarded as a representation by any person that the forward-looking statements set forth herein will be achieved or that any of the contemplated results of such forward looking statements will be achieved. There may be additional risks that Star Peak and Benson Hill presently do not know or that Star Peak and Benson Hill currently believe are immaterial that could also cause actual results to differ from those contained in the forward-looking statements. You should not place undue reliance on forward-looking statements, which speak only as of the date they are made. Neither Star Peak nor Benson Hill undertakes any duty to update these forward-looking statements, except as otherwise required by law.

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/benson-hill-to-host-introductory-webcast-and-qa-for-retail-investors-interested-in-learning-more-about-the-sustainable-food-technology-company-driving-the-plant-based-food-revolution-301373079.html

SOURCE Benson Hill

Yum China to Host Virtual Investor Day and to Report Third Quarter 2021 Financial Results

PR Newswire

SHANGHAI, Sept. 9, 2021 /PRNewswire/ — Yum China Holdings, Inc. (“Yum China” or the “Company”) (NYSE: YUMC and HKEX: 9987) today announced that it will host its virtual Investor Day at 8:00 p.m. U.S. Eastern Time on Wednesday September 22, 2021 (8:00 a.m.Beijing/Hong Kong Time on Thursday September 23, 2021). The event will include senior management presentations and a question and answer session. The event will be webcast live and is expected to last approximately three hours. For additional information and registration details, please visit https://2021investorday.yumchina.com/. A replay of the webcast and presentation slides will also be available through the same link following the event.

Yum China will report its unaudited financial results for the third quarter ending September 30, 2021 at 4:30 p.m. U.S. Eastern Time on Wednesday, October 27, 2021 (4:30 a.m. Beijing/Hong Kong Time on Thursday, October 28, 2021).

Yum China’s management will hold an earnings conference call at 8:00 p.m. U.S. Eastern Time on Wednesday, October 27, 2021 (8:00 a.m.Beijing/Hong Kong Time on Thursday, October 28, 2021).  

A live webcast of the call may be accessed at https://edge.media-server.com/mmc/p/5tbn4t8f.

To join by phone, please register in advance of the conference through the link provided below. Upon registering, you will be provided with participant dial-in numbers, a passcode and a unique registrant ID.

Pre-registration Link: http://apac.directeventreg.com/registration/event/5193096                                               

Conference ID: 5193096           

A replay of the conference call will be available two hours after the call ends until 9:00 a.m. U.S. Eastern Time on Thursday, November 4, 2021 (9:00 p.m.Beijing/Hong Kong Time on Thursday, November 4, 2021) and may be accessed by phone at the following numbers:

U.S.:                               1 855 452 5696
Mainland China:             400 602 2065 or 800 870 0206
Hong Kong:                    +852 3051 2780
U.K.:                               0808 234 0072
International:                  +61 2 8199 0299

Replay access code:        5193096         

Additionally, earnings release, accompanying slides, a live webcast and an archived webcast of this conference call will be available at the Company’s Investor Relations website http://ir.yumchina.com.  

About Yum China Holdings, Inc.

Yum China Holdings, Inc. is a licensee of Yum! Brands in mainland China. It has exclusive rights in mainland China to KFC, China’s leading quick-service restaurant brand, Pizza Hut, the leading casual dining restaurant brand in China, and Taco Bell, a California-based restaurant chain serving innovative Mexican-inspired food. Yum China also owns the Little Sheep, Huang Ji Huang, East Dawning and COFFii & JOY concepts outright. In addition, Yum China has partnered with Lavazza to explore and develop the Lavazza coffee shop concept in China. The Company had 11,023 restaurants in over 1,500 cities at the end of June 2021. Yum China ranked # 363 on the Fortune 500 list and was named to TIME100 Most Influential Companies list in 2021. Yum China has been named the Industry Leader for the Restaurant & Leisure Facilities Industry in the 2020 Dow Jones Sustainability Indices. In 2021, Yum China was named to the Bloomberg Gender-Equality Index and was certified as a Top Employer 2021 in China by the Top Employers Institute, both for the third consecutive year. For more information, please visit http://ir.yumchina.com.


Investor Relations Contact:

Tel: +86 21 2407 7556


[email protected]
  

 


Media Contact
:

Tel: +86 21 2407 7510


[email protected]

 

Cision View original content:https://www.prnewswire.com/news-releases/yum-china-to-host-virtual-investor-day-and-to-report-third-quarter-2021-financial-results-301372381.html

SOURCE Yum China Holdings, Inc.

Impel NeuroPharma Announces Pricing of $45.0 Million Public Offering

SEATTLE, Sept. 09, 2021 (GLOBE NEWSWIRE) — Impel NeuroPharma, Inc. (NASDAQ: IMPL), a commercial-stage biopharmaceutical company developing transformative therapies for people suffering from diseases with high unmet medical needs, with an initial focus on the central nervous system, today announced the pricing of its underwritten public offering of 3,000,000 shares of its common stock at a price to the public of $15.00 per share. All of the shares of common stock are being offered by Impel. The gross proceeds from the offering, before deducting underwriting discounts and commissions and other offering expenses payable by Impel, are expected to be $45.0 million. In addition, Impel has granted the underwriters a 30-day option to purchase up to an additional 450,000 shares of common stock at the offering price, less underwriting discounts and commissions. The offering is expected to close on September 14, 2021, subject to the satisfaction of customary closing conditions.

Cowen and Guggenheim Securities are acting as joint bookrunning managers for the proposed offering. Wedbush PacGrow is acting as lead manager.

A registration statement relating to these securities has been filed with the Securities and Exchange Commission (SEC) and became effective on September 9, 2021. The offering is being made only by means of a prospectus. A copy of the final prospectus relating to the offering, when available, may be obtained from: Cowen and Company, LLC, c/o Broadridge Financial Solutions, Attn: Prospectus Department, 1155 Long Island Avenue, Edgewood, NY 11717, or by telephone at (833) 297-2926 or by email at [email protected]; or Guggenheim Securities, LLC Attention: Equity Syndicate Department, 330 Madison Avenue, New York, NY 10017 or by telephone at (212) 518-9544, or by email at [email protected].

This press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation, or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.

About Impel NeuroPharma:

Impel NeuroPharma, Inc. is a commercial-stage biopharmaceutical company developing transformative therapies for people suffering from diseases with high unmet medical needs, with an initial focus on the central nervous system. Impel offers and is developing treatments that pair its proprietary Precision Olfactory Delivery (POD®) technology with well-established therapeutics. In addition to TRUDHESA™ (dihydroergotamine mesylate) nasal spray, which is approved in the United States for the acute treatment of migraine with or without aura in adults, Impel is also developing INP105 for the acute treatment of agitation and aggression in patients with autism, and INP107 for OFF episodes in Parkinson’s disease.

Cautionary Note on Forward-Looking Statements

This press release contains “forward-looking” statements within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995, including, but not limited to, statements regarding the terms of the proposed public offering, including Impel’s expectations with respect to the gross proceeds, satisfaction of the closing conditions and its ability to complete the public offering. Forward-looking statements can be identified by words such as: “believe,” “may,” “will,” “potentially,” “estimate,” “continue,” “anticipate,” “intend,” “could,” “would,” “project,” “plan,” “expect” or the negative or plural of these words or similar expressions. These statements are subject to numerous risks and uncertainties that could cause actual results and events to differ materially from those anticipated. Many of these risks are described in greater detail in Impel’s filings with the SEC, including the Risk Factors section in Impel’s Registration Statement on Form S-1 filed with the SEC on September 7, 2021, as well as Impel’s annual, quarterly and periodic reports under the Securities Exchange Act of 1934. Any forward-looking statements in this press release speak only as of the date of this press release. Impel assumes no obligation to update forward-looking statements whether as a result of new information, future events or otherwise, after the date of this press release.


Contact

Investor Relations:

Christina Tartaglia
Stern Investor Relations
Phone: (1) 212-362-1200
Email: [email protected]

Media Relations:

Melyssa Weible
Elixir Health Public Relations
Phone: (1) 201-723-5805
Email: [email protected]

 



Destination XL Group, Inc. Announces Pricing of Offering of Common Stock by Selling Stockholder

CANTON, Mass., Sept. 09, 2021 (GLOBE NEWSWIRE) — Destination XL Group, Inc. (NASDAQ: DXLG), the leading omni-channel specialty retailer of Big + Tall men’s clothing and shoes, today announced the pricing of an underwritten public offering of 5,733,076 shares of common stock by Red Mountain Partners, L.P. at a public offering price of $6.10 per share. The selling stockholder will receive all of the net proceeds from the offering. The Company is not offering any of its shares of common stock and will not receive any of the proceeds from the offering, but will bear certain costs associated with the sale of such shares, other than underwriting discounts and commissions and the expenses of the underwriters. The offering is expected to close on September 14, 2021, subject to customary closing conditions.

D.A. Davidson & Co. and Craig-Hallum Capital Group LLC are acting as joint book-running managers for the offering.

A shelf registration statement on Form S-3 (including a base prospectus) (File No. 333-256990) relating to these securities has been filed with the Securities and Exchange Commission (“SEC”) and became effective on June 21, 2021. A preliminary prospectus supplement relating to these securities has been filed with the SEC. Before you invest, you should read the registration statement, the base prospectus, the preliminary prospectus supplement, and other documents filed with the SEC and incorporated by reference therein for more complete information about the Company and this offering. The offering is being made only by means of a prospectus and prospectus supplement. Copies of the prospectus and final prospectus supplement relating to this offering may be obtained, when available, by visiting the SEC’s website at www.sec.gov, or contacting the offices of D.A. Davidson & Co. at Attention: Equity Syndicate, 8 Third Street North, Great Falls, MT 59401, telephone: (800) 332-5915, or by email: [email protected], or by contacting Craig-Hallum Capital Group LLC, 222 South Ninth Street, Suite 350, Minneapolis, MN 55402, Attn: Equity Capital Markets, telephone: (612) 334-6300 or by e-mail: [email protected].

This press release shall not constitute an offer to sell or a solicitation of an offer to buy these securities, nor shall there be any offer or sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of any such state or jurisdiction.

Forward-Looking Statements

Certain statements and information contained in this press release constitute forward-looking statements under the federal securities laws, including statements regarding the expected closing of the offering. The Company’s actual results may differ materially from forward-looking statements made by the Company. The Company encourages readers of forward-looking information concerning the Company to refer to its filings with the Securities and Exchange Commission, including without limitation, its Annual Report on Form 10-K filed on March 19, 2021, its Quarterly Reports on Form 10-Q and other filings with the Securities and Exchange Commission that set forth certain risks and uncertainties that may have an impact on future results and direction of the Company. Such risks and uncertainties may include, but are not limited to, the risk that the offering of common stock may not close.

Forward-looking statements contained in this press release speak only as of the date of this release. Subsequent events or circumstances occurring after such date may render these statements incomplete or out of date. The Company undertakes no obligation and expressly disclaims any duty to update such statements.

About Destination XL Group, Inc.

Destination XL Group, Inc. is the leading retailer of Men’s Big + Tall apparel that delivers a Big + Tall shopping experience that fits — fits his body, fits his style, fits his life. Subsidiaries of Destination XL Group, Inc. operate DXL Big + Tall retail and outlet stores throughout the United States as well as Toronto, Canada, Casual Male XL retail and outlet stores in the United States, and an e-commerce website, DXL.com, which offers a multi-channel solution similar to the DXL store experience with the most extensive selection of online products available anywhere for Big + Tall men. The Company is headquartered in Canton, Massachusetts. For more information, please visit the Company’s investor relations website: https://investor.dxl.com.

Investor Contact:
[email protected]
603-933-0541



Endo Settles New York State Opioid Cases and Provides Update on Remaining Opioid Litigation

PR Newswire

DUBLIN, Sept. 9, 2021 /PRNewswire/ — Endo International plc (NASDAQ: ENDP) (“Endo”) today announced that it and its wholly-owned subsidiaries, Endo Health Solutions Inc., Endo Pharmaceuticals Inc., Par Pharmaceutical, Inc. and Par Pharmaceutical Companies, Inc., have settled three consolidated cases pending in Suffolk County Supreme Court in the State of New York:  County of Suffolk v. Purdue Pharma L.P. et al., Case No. 400001/2017; County of Nassau v. Purdue Pharma L.P. et al., Case No. 400008/2017; and The State of New York v. Purdue Pharma L.P. et al., Case No. 400016/2018.

The plaintiffs in the foregoing cases asserted various claims relating to the defendants’ marketing and sale of prescription opioid medications and/or alleged failures to take adequate steps to identify and report suspicious orders. A jury trial on liability has been ongoing since June 2021.

As a result of the settlement, Endo’s subsidiaries have been severed from the trial.  The settlement fully and finally resolves all of the asserted claims in exchange for a total payment of $50 million.  The settlement includes no admission of wrongdoing, fault or liability of any kind by Endo or its subsidiaries, and the settlement value should not be extrapolated to any other opioid-related cases or claims.  

While litigation of the remaining opioid claims is ongoing, Endo is focused on its primary goal of achieving a global settlement. Endo is also currently exploring other strategic alternatives and may seek to implement one or more of those alternatives in the event it is unable to achieve a global settlement.  Endo cannot speculate on the likelihood, nature or timing of any outcome.  

About Endo International plc

Endo (NASDAQ: ENDP) is a specialty pharmaceutical company committed to helping everyone we serve live their best life through the delivery of quality, life-enhancing therapies. Our decades of proven success come from a global team of passionate employees collaborating to bring the best treatments forward. Together, we boldly transform insights into treatments benefiting those who need them, when they need them. Learn more at www.endo.com or connect with us on LinkedIn.

Cautionary Note Regarding Forward-Looking Statements

Certain information in this press release may be considered “forward-looking statements,” within the meaning of the Private Securities Litigation Reform Act of 1995 and any applicable Canadian securities legislation including, but not limited to, the statements relating to the status and outcome of litigation or settlement discussions.  All forward-looking statements in this press release reflect Endo’s current expectations of future events based on information available to Endo as of the date of this press release.  If underlying assumptions prove inaccurate or unknown risks or uncertainties materialize, actual results could vary materially from Endo’s expectations and projections, including with respect to the impact of the New York case, including the settlement, or any other litigation, investigation or settlement proceeding on our financial statements, including our cash flows from operations; our ability to adjust to changing market conditions; our ability to attract and retain key personnel; our ability to maintain compliance with our financial obligations under certain of our outstanding debt obligations, causing a downgrade of our debt and long-term corporate ratings (which could increase our cost of capital) and exposing us to potential events of default (if not cured or waived) under financial and operating covenants contained in our or our subsidiaries’ outstanding indebtedness; our ability to incur additional borrowings under the covenants in our then-existing facilities or to obtain additional debt or equity financing for working capital, capital expenditures, business development, debt service requirements, acquisitions or general corporate or other purposes, or to refinance our indebtedness; and/or a significant reduction in our short-term and long-term revenues and/or otherwise cause us to be unable to fund our operations and liquidity needs, such as future capital expenditures and payment of our indebtedness.  The occurrence or possibility of any such result may cause us to pursue one or more significant corporate transactions or remedial measures, including on a preventative or proactive basis. Actions that may be evaluated or pursued could include reorganization or restructuring activities of all or a portion of our business, asset sales or other divestitures, cost-saving initiatives or other corporate realignments, seeking strategic partnerships and exiting certain product or geographic markets. Some of these measures could take significant time to implement and others may require judicial or other third party approval. Any such actions may be complex, could entail significant costs and charges or could otherwise negatively impact shareholder value, and there can be no assurance that we will be able to accomplish any of these alternatives on terms acceptable to us, or at all, or that they will result in their intended benefits.  Other risks and uncertainties include general industry and market conditions; technological advances and patents attained by competitors; challenges inherent in the research and development and regulatory processes, including regulatory decisions, product recalls, withdrawals and other unusual items; challenges related to product marketing, such as the unpredictability of market acceptance for new products and/or the acceptance of new indications for such products; inconsistency of treatment results among patients; potential difficulties in manufacturing; general economic conditions; and governmental laws and regulations affecting domestic and foreign operations.  Endo expressly disclaims any intent or obligation to update these forward-looking statements except as required by law.  Additional information concerning these and other risk factors can be found in Endo’s periodic reports filed with the U.S. Securities and Exchange Commission and in Canada on the System for Electronic Data Analysis and Retrieval, including current reports on Form 8-K, quarterly reports on Form 10-Q and annual reports on Form 10-K. 

 

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/endo-settles-new-york-state-opioid-cases-and-provides-update-on-remaining-opioid-litigation-301373074.html

SOURCE Endo International plc

Penn Virginia Announces Participation in Upcoming Conference

HOUSTON, Sept. 09, 2021 (GLOBE NEWSWIRE) — Penn Virginia Corporation (“Penn Virginia” or the “Company”) (NASDAQ: PVAC) today announced its participation in an upcoming investor conference.

Darrin Henke, President and Chief Executive Officer, is scheduled to present at the Barclays CEO Energy-Power Conference on September 10, 2021 at 9:45 am ET. The Company’s management will participate in meetings immediately following this presentation. A link to the presentation slides will be available on the Company’s website at www.pennvirginia.com.

About Penn Virginia Corporation

Penn Virginia Corporation is a pure-play independent oil and gas company engaged in the development and production of oil, NGLs, and natural gas, with operations in the Eagle Ford shale in south Texas. For more information, please visit our website at www.pennvirginia.com. The information on the Company’s website is not part of this release.

Contact

Clay Jeansonne
Investor Relations
Ph: (713) 722-6540
E-Mail: [email protected]



Bumble Inc. Announces Pricing of Secondary Offering of Shares of Class A Common Stock

AUSTIN, Texas, Sept. 09, 2021 (GLOBE NEWSWIRE) — Bumble Inc. (Nasdaq: BMBL) (“Bumble”) announced today the pricing of a previously announced secondary offering of 18,000,000 shares of Bumble’s Class A common stock by certain selling stockholders affiliated with Blackstone Inc. (the “Selling Stockholders”) at a price to the public of $54.00 per share. The Selling Stockholders have also granted the underwriters a 30-day option to purchase up to an additional 2,700,000 shares of Bumble’s Class A common stock. The offering is expected to close on September 15, 2021, subject to customary closing conditions.

Bumble is not selling any shares of Class A common stock in the offering and will not receive any of the proceeds from the sale. Bumble will bear the costs associated with the sale of such shares, other than the underwriting discounts.

Goldman Sachs & Co. LLC and Citigroup are acting as joint lead book-running managers and as representatives of the underwriters for the offering. Morgan Stanley and J.P. Morgan are acting as joint book-running managers for the offering. Evercore ISI, Jefferies and RBC Capital Markets are acting as joint book-runners for the offering. Blackstone, BMO Capital Markets, BTIG, Cowen, Mizuho Securities, Raymond James, Stifel, SMBC Nikko, AmeriVet Securities, C.L. King & Associates, Drexel Hamilton, Loop Capital Markets, R. Seelaus & Co., LLC, Ramirez & Co., Inc., Siebert Williams Shank and Telsey Advisory Group are acting as co-managers for the offering.

The offering of these securities is being made only by means of a prospectus. When available, copies of the preliminary prospectus and the prospectus relating to this offering may be obtained from: Goldman Sachs & Co. LLC, Attention: Prospectus Department, 200 West Street, New York, New York 10282, telephone: (866) 471-2526, facsimile: 212-902-9316, email: [email protected]; or Citigroup Global Markets Inc., Attention: Prospectus Department, c/o Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood, New York 11717, telephone: (800) 831-9146, email: [email protected].

A registration statement relating to these securities was filed with, and declared effective by, the Securities and Exchange Commission (the “SEC”). This press release shall not constitute an offer to sell or the solicitation of an offer to buy these securities, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.

About Bumble

Bumble Inc. is the parent company of Bumble and Badoo, two of the world’s highest-grossing dating apps with millions of users worldwide. The Bumble platform enables people to connect and build equitable and healthy relationships. Founded by CEO Whitney Wolfe Herd in 2014, the Bumble app is one of the first dating apps built with women at the center, and the Badoo app, which was founded in 2006, is one of the pioneers of web and mobile dating products. Bumble currently employs over 800 people in offices in Austin, Barcelona, London, and Moscow.

Forward-Looking Statements

This press release contains forward-looking statements. Forward-looking statements include all statements that are not historical facts. In some cases, you can identify these forward-looking statements by the use of words such as “outlook,” “believe(s),” “expect(s),” “potential,” “continue(s),” “may,” “will,” “should,” “could,” “would,” “seek(s),” “predict(s),” “intend(s),” “trends,” “plan(s),” “estimate(s),” “anticipates,” “projection,” “will likely result” and or the negative version of these words or other comparable words of a future or forward-looking nature. Such forward-looking statements are subject to various risks and uncertainties. Accordingly, there are or will be important factors that could cause actual outcomes or results to differ materially from those indicated in these statements. These factors include but are not limited to those described under “Risk Factors” in Bumble’s registration statement relating to the offering and “Item 1A. Risk Factors” in Bumble’s Annual Report on Form 10-K for the fiscal year ended December 31, 2020, as filed with the SEC, as such factors may be updated from time to time in Bumble’s periodic filings with the SEC. These factors should not be construed as exhaustive and should be read in conjunction with the other cautionary statements that are included in Bumble’s filings with the SEC. We undertake no obligation to publicly update or review any forward-looking statement, whether as a result of new information, future developments or otherwise, except as required by law.

Source: Bumble Inc.

Investor Contact

[email protected]

Media Contact

[email protected]



VICI Properties Inc. Announces Pricing of Public Offering of Common Stock

VICI Properties Inc. Announces Pricing of Public Offering of Common Stock

NEW YORK–(BUSINESS WIRE)–
VICI Properties Inc. (NYSE: VICI) (“VICI Properties” or the “Company”), an experiential asset real estate investment trust, today announced the pricing of an underwritten public offering of 100,000,000 shares of its common stock at a public offering price of $29.50 per share. The Company is issuing and selling 50,000,000 shares directly to the underwriters at closing and the underwriters are purchasing 50,000,000 shares related to the forward sale agreements described below. The underwriters were also granted a 30-day option to purchase up to an additional 15,000,000 shares from the Company. The offering is expected to close on September 14, 2021, subject to customary closing conditions.

Morgan Stanley, Citigroup, J.P. Morgan and Goldman Sachs & Co. LLC are acting as joint book-running managers and as representatives of the underwriters in the offering. BofA Securities, Deutsche Bank Securities, Barclays and Wells Fargo Securities are acting as bookrunners in the offering. Citizens Capital Markets, Stifel, Truist Securities, CBRE, Baird, Capital One Securities, KeyBanc Capital Markets, Ladenburg Thalmann, Loop Capital Markets, Macquarie Capital, Raymond James, Scotiabank, SMBC Nikko, UBS Investment Bank and Wolfe | Nomura Strategic Alliance are acting as co-managers in the offering.

The Company has entered into separate forward sale agreements with each of Morgan Stanley, Citigroup, J.P. Morgan and Goldman Sachs & Co. LLC (or their respective affiliates) (the “forward purchasers”) with respect to 50,000,000 shares of common stock covered by the offering. In connection with the forward sale agreements, the forward purchasers or their respective affiliates are expected to borrow and sell to the underwriters an aggregate of 50,000,000 shares of common stock that will be delivered in the offering.

Subject to its right to elect cash or net share settlement under certain conditions, the Company intends to deliver, upon full physical settlement of the forward sale agreements on one or more dates specified by the Company occurring no later than approximately twelve months following the completion of the offering, an aggregate of 50,000,000 shares of common stock to the forward purchasers in exchange for cash proceeds per share equal to the applicable forward sale price, which will initially be the public offering price less the underwriting discount and will be subject to certain adjustments as provided in the forward sale agreements.

The Company will receive proceeds from its direct sale of 50,000,000 shares of common stock in the offering, but it will not initially receive any proceeds from the sale of shares by the forward purchasers or their respective affiliates. VICI expects to use the net proceeds from the sale of shares of our common stock and expected cash proceeds received upon full physical settlement of the forward sale agreements to pay down current indebtedness and to fund a portion of the purchase price of the previously announced pending acquisition of the land and real estate assets associated with The Venetian Resort and The Venetian Expo in Las Vegas, Nevada.

The offering is being made pursuant to an effective shelf registration statement and will be made only by means of a prospectus supplement and a related prospectus relating to such offering, a copy of which may be obtained, when available, from: Morgan Stanley, Attention: Prospectus Department, 180 Varick Street, 2nd Floor, New York, NY 10014; Citigroup, c/o Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood, NY 11717, telephone: (800) 831-9146 or email: [email protected]; J.P. Morgan, c/o Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood, New York 11717, telephone: (866) 803-9204; and Goldman Sachs & Co. LLC, Attention: Prospectus Department, 200 West Street, New York, NY 10282 (telephone: (866) 471-2526 or email: [email protected]).

This press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation, or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.

About VICI Properties

VICI Properties Inc. is an experiential real estate investment trust that owns one of the largest portfolios of market-leading gaming, hospitality and entertainment destinations, including the world-renowned Caesars Palace. VICI Properties’ national, geographically diverse portfolio consists of 28 gaming facilities comprising over 47 million square feet and features approximately 17,800 hotel rooms and more than 200 restaurants, bars, nightclubs and sportsbooks. Its properties are leased to industry leading gaming and hospitality operators, including Caesars Entertainment, Inc., Century Casinos, Inc., the Eastern Band of Cherokee Indians, Hard Rock International Inc., JACK Entertainment LLC and Penn National Gaming, Inc. VICI Properties also has an investment in the Chelsea Piers, New York facility and owns four championship golf courses and 34 acres of undeveloped land adjacent to the Las Vegas Strip. VICI Properties’ strategy is to create the nation’s highest quality and most productive experiential real estate portfolio.

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the federal securities laws. You can identify these statements by our use of the words “assumes,” “believes,” “estimates,” “expects,” “guidance,” “intends,” “plans,” “projects,” and similar expressions that do not relate to historical matters. All statements other than statements of historical fact are forward-looking statements. You should exercise caution in interpreting and relying on forward-looking statements because they involve known and unknown risks, uncertainties, and other factors which are, in some cases, beyond the Company’s control and could materially affect actual results, performance, or achievements. Important risk factors that may affect the Company’s business, results of operations and financial position (including those stemming from the COVID-19 pandemic and changes in the economic conditions as a result thereof) are detailed from time to time in the Company’s filings with the Securities and Exchange Commission and include, among others, risks related to the method of settlement of the Company’s forward sale agreements, the form and amount of proceeds of such settlement and the ability to complete the acquisition of the land and real estate assets associated with the property known as The Venetian Resort and The Venetian Expo in Las Vegas, Nevada. The Company does not undertake any obligation to update or revise any forward-looking statement, whether as a result of new information, future events, or otherwise, except as may be required by applicable law.

Investor Contacts:

[email protected]

(646) 949-4631

Or

David Kieske

EVP, Chief Financial Officer

[email protected]

Danny Valoy

Vice President, Finance

[email protected]

KEYWORDS: Nevada New York United States North America

INDUSTRY KEYWORDS: Professional Services Entertainment Commercial Building & Real Estate Finance Construction & Property REIT Casino/Gaming

MEDIA:

agilon health Announces Pricing of Secondary Offering

agilon health Announces Pricing of Secondary Offering

LONG BEACH, Calif.–(BUSINESS WIRE)–
agilon health, inc. (NYSE: AGL), the company transforming health care for seniors by empowering primary-care physicians to focus on the entire health of their patients, announced the pricing of its previously announced underwritten public offering of 17,000,000 shares of its common stock by certain selling stockholders at a public offering price of $30.00 per share. Certain of these selling stockholders have granted the underwriters a 30-day option to purchase up to an additional 2,550,000 shares of agilon health’s common stock. agilon health will not receive any proceeds from the secondary offering. The offering is expected to close on September 14, 2021, subject to customary closing conditions.

J.P. Morgan, Goldman Sachs & Co. LLC, and BofA Securities are acting as lead book-running managers for the proposed offering. Deutsche Bank Securities, Wells Fargo Securities, Wolfe | Nomura Strategic Alliance, William Blair, and Truist Securities are acting as additional book-running managers.

A registration statement relating to these securities was declared effective by the U.S. Securities and Exchange Commission on September 9, 2021. The offering is being made only by means of a prospectus. Copies of the final prospectus, when available, may be obtained from: J.P. Morgan Securities LLC, c/o Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood, NY 11717, or by telephone at (866) 803-9204, or by email at [email protected]; or Goldman Sachs & Co. LLC, Attention: Prospectus Department, 200 West Street, New York, New York 10282, telephone: 1-866-471-2526, facsimile: 212-902-9316 or by emailing [email protected]; or BofA Securities, Attention: Prospectus Department, NC1-004-03-43, 200 North College Street, 3rd Floor, Charlotte, NC 28255-0001, or by email at [email protected].

This press release shall not constitute an offer to sell or the solicitation of an offer to buy these securities, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction. Any offers, solicitations or offers to buy, or any sales of securities will be made in accordance with the registration requirements of the Securities Act of 1933, as amended.

“Wolfe | Nomura Strategic Alliance” is the marketing name used by Wolfe Research Securities and Nomura Securities International, Inc. in connection with certain equity capital markets activities conducted jointly by the firms. For these activities, Nomura serves as the underwriter, placement agent, or initial purchaser (as applicable) and Wolfe Research Securities provides sales support services, investor education, and/or independent equity research services.

About agilon health

agilon health is transforming health care for seniors by empowering primary-care physicians to focus on the entire health of their patients. Through our partnerships and our platform, agilon is leading the nation in creating the system we need – one built on the value of care, not the volume of fees. We honor the independence of local physicians and serve as their partners so they can be the doctors they trained to be. agilon provides the capital, data, payor relationships, executive experience and contract support that allow physician groups to take on the risk of total care for their most vulnerable patients. The result: healthier communities, and doctors who can devote the right amount of time with the patients who need it most. With rapidly growing appeal, agilon is scaled to grow and is here to help our nation’s best independent physician groups have a sustained, thriving future. Together, we are reinventing primary care.

Cautionary Note Regarding Forward-Looking Statements

This press release contains statements that constitute “forward-looking statements,” including with respect to the proposed secondary offering. No assurance can be given that the offering discussed above will be completed on the terms described, or at all. Forward-looking statements are subject to numerous conditions, many of which are beyond the control of agilon health, including those set forth in the Risk Factors section of agilon health’s most recent Quarterly Report on Form 10-Q and in the registration statement for this offering and the preliminary prospectus included therein, as filed with the Securities and Exchange Commission. Copies are available on the SEC’s website at www.sec.gov. agilon health undertakes no obligation to update these statements for revisions or changes after the date of this press release, except as required by law.

Investor Contact

Matthew Gillmor

VP, Investor Relations

[email protected]

Media Contact

Claire Mulhearn

VP, Corporate Communications

[email protected]

KEYWORDS: United States North America California

INDUSTRY KEYWORDS: General Health Health Seniors Consumer

MEDIA:

Logo
Logo

Quanta Services Announces Pricing of Senior Notes Offering

PR Newswire

HOUSTON, Sept. 9, 2021 /PRNewswire/ — Quanta Services, Inc. (NYSE: PWR) announced today the pricing of its offering (the Offering) of (i) $500,000,000 aggregate principal amount of 0.950% senior notes due 2024 (the “2024 Notes”) at a price to the public of 99.946% of their face value, (ii) $500,000,000 aggregate principal amount of 2.350% senior notes due 2032 (the “2032 Notes”) at a price to the public of 99.939% of their face value and (iii) $500,000,000 aggregate principal amount of 3.050% senior notes due 2041 (together with the 2024 Notes and the 2032 Notes, the “Notes”) at a price to the public of 99.480% of their face value. The Offering is expected to close on September 23, 2021, subject to the satisfaction of customary closing conditions. Quanta intends to use the net proceeds from the Offering, together with borrowings under the term loan facility it is negotiating, which the company expects to enter following the closing of the Offering, as well as borrowings under its revolving credit facility or cash on hand, or a combination thereof, if necessary, to finance the cash portion of the consideration for its pending acquisition of Blattner Holding Company.

BofA Securities, Inc. and Wells Fargo Securities, LLC acted as joint book-running managers for the Offering.

The Offering is being made pursuant to an effective shelf registration statement on Form S-3 previously filed with the U.S. Securities and Exchange Commission (the “SEC”) on September 14, 2020, and only by means of a prospectus supplement and accompanying base prospectus. Copies of the prospectus supplement and accompanying base prospectus relating to the Offering may be obtained from BofA Securities, Inc., NC1-004-03-43, 200 North College Street, 3rd floor, Charlotte NC  28255-0001, Attn: Prospectus Department, Email: [email protected] and Wells Fargo Securities, LLC toll-free at 1-800-645-3751. You may also obtain these documents free of charge by visiting the Electronic Data Gathering and Analysis Retrieval System (EDGAR) on the SEC’s website at www.sec.gov.  

This news release does not constitute an offer to sell or a solicitation of an offer to buy the securities described herein, nor shall there be any offer, solicitation or sale of the Notes in any state or jurisdiction in which such an offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.

About Quanta Services
Quanta Services is a leading specialized contracting services company, delivering comprehensive infrastructure solutions for the utility, communications, pipeline and energy industries. Quanta’s comprehensive services include designing, installing, repairing and maintaining energy and communications infrastructure. With operations throughout the United States, Canada, Australia and select other international markets, Quanta has the manpower, resources and expertise to safely complete projects that are local, regional, national or international in scope. For more information, visit www.quantaservices.com.

Forward Looking Statements
This press release (and any oral statements regarding the subject matter of this press release) contains forward-looking statements intended to qualify for the “safe harbor” from liability established by the Private Securities Litigation Reform Act of 1995.  Forward-looking statements include, but are not limited to, statements relating to the anticipated timing of the closing of the Offering, Quanta’s intended use of proceeds therefrom, the closing of the Blattner Acquisition, and Quanta’s entry into a new term loan facility, as well as statements reflecting expectations, intentions, assumptions or beliefs about future events and other statements that do not relate strictly to historical or current facts. Although Quanta’s management believes that the expectations reflected in such forward-looking statements are reasonable, it can give no assurance that such expectations will prove to be correct. These statements can be affected by inaccurate assumptions and by a variety of known and unknown risks and uncertainties that are difficult to predict or beyond Quanta’s control, including, among others, those described in the prospectus supplement and accompanying base prospectus relating to the Offering and other risks and uncertainties detailed in Quanta’s Annual Report on Form 10-K for the year ended Dec. 31, 2020, Quanta’s Quarterly Reports on Form 10-Q for the quarters ended Mar. 31, 2021 and Jun. 30, 2021 and any other documents that Quanta files with the SEC. For a discussion of these risks, uncertainties and assumptions, investors are urged to refer to Quanta’s documents filed with the SEC that are available through Quanta’s website at www.quantaservices.com or through EDGAR at www.sec.gov. Should one or more of these risks materialize, or should underlying assumptions prove incorrect, actual results may vary materially from those expressed or implied in any forward-looking statements. Investors are cautioned not to place undue reliance on these forward-looking statements, which are current only as of this date. Quanta does not undertake and expressly disclaims any obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. Quanta further expressly disclaims any written or oral statements made by any third party regarding the subject matter of this press release.

Derrick Jensen, CFO
Kip Rupp, CFA, IRC – Investors                      
Quanta Services, Inc.                               
(713) 629-7600

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/quanta-services-announces-pricing-of-senior-notes-offering-301373067.html

SOURCE Quanta Services, Inc.